Agneta K. Hurst

541 total citations
13 papers, 385 citations indexed

About

Agneta K. Hurst is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pharmacology. According to data from OpenAlex, Agneta K. Hurst has authored 13 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Agneta K. Hurst's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Heart Failure Treatment and Management (2 papers). Agneta K. Hurst is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Analytical Methods in Pharmaceuticals (3 papers) and Heart Failure Treatment and Management (2 papers). Agneta K. Hurst collaborates with scholars based in United States. Agneta K. Hurst's co-authors include Avraham Shotan, Uri Elkayam, Josef Widerhorn, Roger W. Jelliffe, Earl C. Harrison, Teresa Iglesias, Julián Rodrı́guez, Robert T. Koda, Ken Iseri and T. Murphy Goodwin and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Agneta K. Hurst

13 papers receiving 354 citations

Peers

Agneta K. Hurst
Melisa Cooper United Kingdom
C. P. Swainson United Kingdom
Michael Ward Australia
P. Tejada Spain
K. Koch Germany
Julia Botha South Africa
Paola Mian Netherlands
Béatrice Krauer Switzerland
Melisa Cooper United Kingdom
Agneta K. Hurst
Citations per year, relative to Agneta K. Hurst Agneta K. Hurst (= 1×) peers Melisa Cooper

Countries citing papers authored by Agneta K. Hurst

Since Specialization
Citations

This map shows the geographic impact of Agneta K. Hurst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agneta K. Hurst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agneta K. Hurst more than expected).

Fields of papers citing papers by Agneta K. Hurst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agneta K. Hurst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agneta K. Hurst. The network helps show where Agneta K. Hurst may publish in the future.

Co-authorship network of co-authors of Agneta K. Hurst

This figure shows the co-authorship network connecting the top 25 collaborators of Agneta K. Hurst. A scholar is included among the top collaborators of Agneta K. Hurst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agneta K. Hurst. Agneta K. Hurst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hurst, Agneta K., et al.. (1998). Pharmacokinetic and Pharmacodynamic Evaluation of Atenolol during and after Pregnancy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(4). 840–846. 15 indexed citations
2.
Elkayam, Uri, et al.. (1996). Evidence for attenuated heart rate control with beta blockade in women with heart disease during pregnancy: A pharmacokinetic and pharmacodynamic study. Journal of the American College of Cardiology. 27(2). 79–79. 1 indexed citations
3.
Hurst, Agneta K., et al.. (1995). High-Performance Liquid Chromatographic Method for Determination of Atenolol from Human Plasma and Urine: Simultaneous Fluorescence and Ultraviolet Detection. Journal of Liquid Chromatography. 18(4). 791–806. 13 indexed citations
4.
Shotan, Avraham, Josef Widerhorn, Agneta K. Hurst, & Uri Elkayam. (1994). Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. The American Journal of Medicine. 96(5). 451–456. 184 indexed citations
5.
Shotan, Avraham, Anil Mehra, Enrique Ostrzega, et al.. (1993). Plasma cyclic guanosine monophosphate in chronic heart failure: Hemodynamic and neurohormonal correlations and response to nitrate therapy. Clinical Pharmacology & Therapeutics. 54(6). 638–644. 11 indexed citations
6.
Iglesias, Teresa, et al.. (1991). Individualising Gentamicin Dosage Regimens. Clinical Pharmacokinetics. 21(6). 461–478. 48 indexed citations
7.
Hurst, Agneta K., et al.. (1990). Application of a Bayesian method to monitor and adjust vancomycin dosage regimens. Antimicrobial Agents and Chemotherapy. 34(6). 1165–1171. 73 indexed citations
8.
Hurst, Agneta K., et al.. (1988). Use of Computer-Assisted Case Presentations in a Clinical Therapeutics Course. American Journal of Pharmaceutical Education. 52(1). 56–58. 1 indexed citations
9.
Jelliffe, Roger W., et al.. (1988). Factors Affecting Precise Control of Serum Drug Levels in Patients. IFAC Proceedings Volumes. 21(1). 145–147. 1 indexed citations
10.
Hurst, Agneta K., et al.. (1987). Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis.. PubMed. 6(3). 234–8. 9 indexed citations
11.
Hurst, Agneta K., et al.. (1986). Blood-sampling strategy for monitoring continuous intravenous heparin therapy.. PubMed. 5(6). 510–3. 2 indexed citations
12.
Rodman, John H., Agneta K. Hurst, Thomas D. Gaarder, Jordan L. Cohen, & Roger W. Jelliffe. (1982). N-Acetylprocainamide kinetics and clinical response during repeated dosing. Clinical Pharmacology & Therapeutics. 32(3). 378–386. 7 indexed citations
13.
Hurst, Agneta K.. (1973). Metaproterenol, a potent and safe bronchodilator.. PubMed. 31(10). 460–6. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026